Insulin is commonly known as the key hormone in diabetes. But even for people who don't have the disease, it can be ...

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...

A recent study shows that traditional insulin resistance measures such as HOMA-IR are more predictive of insulin resistance ...

Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...

McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...

Gut microbes in early life play a key role in shaping insulin production and diabetes risk, with Candida dubliniensis showing ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

Iraq partners with German & Dutch (Byton) firms via MoU to build an insulin production plant in Nineveh, boosting local ...